Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bayona J, et al.
2012-08-28 • PLOS Medicine
2012-08-28 • PLOS Medicine
Treatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic, expensive, and has generally poor outcomes. We undertook an individual patient data meta-analysis to assess the ...
2012-02-08 • International Journal of Tuberculosis and Lung Disease
2012-02-08 • International Journal of Tuberculosis and Lung Disease
BACKGROUND: Current treatment for drug-resistant tuberculosis (DR-TB) is inadequate, and outcomes are significantly poorer than for drug-susceptible TB, particularly for patients previou...